IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo
✍ Scribed by Kröger, Andrea; Dallügge, Andreas; Kirchhoff, Sabine; Hauser, Hansjörg
- Book ID
- 110067377
- Publisher
- Nature Publishing Group
- Year
- 2003
- Tongue
- English
- Weight
- 342 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0950-9232
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The removal of serum from the medium of uninfected fibroblasts decreased the rate of uptake of uridine, 2‐deoxyglucose, α‐aminoisobutyrate and thymidine. Its subsequent addition rapidly and reversibly stimulated the uptake of all the nutrients but thymidine and this response was not inh
The effects of magnesium (Mg) restriction on cell growth and the cell cycle were determined in transformed (TRL-8) and non-transformed (TRL-12-15) epithelial-like rat liver cells. Cells were cultured in RPMI 1640 medium in which the Mg concentration was reduced to 0.5, 0.1, and 0 x the concentration
## Abstract Recent studies have shown that the proliferation of some tumor cells is dependent on autocrine growth loops that require amidated autocrine growth factors. Peptidylglycine α‐monooxygenase (PAM) is required for amidation of these growth factors and, therefore, this enzyme is an attractiv
IRF2 is a transcription factor, possessing oncogenic potential, responsible for both the repression of growth-inhibiting genes (interferon) and the activation of cell cycle-regulated genes (histone H4). Surprisingly little is known about the post-translational modification of this factor. In this st